Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 351 - 360 of 924
  • Penn researchers to study the impact of environmental and economic interventions on reducing health disparities in Black Philadelphia neighborhoods

    A grant of nearly $10M will fund research to investigate the impact of neighborhood place-based and financial well-being interventions, targeting the root causes of structural racism that contribute to poor health in Black communities.

    FULL STORY AT Penn Medicine News

  • Penn Anti-Cancer Engineering Center will delve into the disease’s physical fundamentals

    The Penn Anti-Cancer Engineering Center will study fundamental forces and associated challenges that determine how cancer grows and spreads, looking for mechanisms that could lead to new treatments or preventative therapies.

    FULL STORY AT Penn Engineering Today

  • Newly rediscovered historical medical notebooks solve some mysteries about famous Muybridge images

    Muybridge was recruited by Penn in 1884 for a project using emerging motion picture technology to understand human and animal locomotion. He partnered with Francis Dercum, then chief of HUP’s Dispensary for Nervous Diseases, to study how neurological conditions impacted the movements of neurology patients. This year, Geoffrey Noble, a former neurology resident in the Perelman School of Medicine, found the original clinical records for nine of Muybridge and Dercum’s photographic subjects.

    FULL STORY AT Penn Medicine News

  • Penn Medicine researchers awarded $14 million to launch Suicide Prevention Implementation Research Center

    Led by Maria A. Oquendo and Gregory K. Brown, the INSPIRE center brings together psychiatry, implementation science, health economics, machine learning, and other interdisciplinary research experts to apply innovative approaches to suicide prevention.

    FULL STORY AT Penn Medicine News

  • Pennovation Lab welcomes new tenant Interius BioTherapeutics

    Co-founded by associate professor of medicine Saar Gill, Interius is developing new ways to engineer cells inside the human body, and aims to transform cell and gene therapy through direct patient administration of genetic medicines to generate therapeutic immune and blood cells.

    FULL STORY AT Pennovation Works

  • National Academy of Medicine recognizes Christina Roberto as a 2021 Emerging Leader in Health and Medicine scholar

    The CHIBE associate director and the Mitchell J. Blutt and Margo Krody Blutt Presidential Associate Professor of Health Policy and the rest of the 2021 scholar class will participate in a variety of activities over a 3-year term, including attending meetings, publishing NAM perspectives, and planning a leaders forum.

    FULL STORY AT Center for Health Incentives and Behavioral Economics

  • Creating green space and supporting student-athletes through Penn Medicine CAREs

    Volunteer initiatives to create more green space for improved mental health in Philadelphia, and nutritional support for students participating in after-school sports, are among the 22 projects to receive Penn Medicine CAREs funding this quarter.

    FULL STORY AT Penn Medicine News

  • Penn Nursing dean to be honored for shaping health policy

    Antonia Villarruel is set to receive the 2021 Health Care Leader Award from the American Academy of Nursing, which recognizes an influential national leader dedicated to improving the health of the nation through contributions to organizational excellence.

    FULL STORY AT Penn Nursing News

  • South Jersey’s first Proton Therapy Center takes giant step forward with delivery of 90-ton particle accelerator from Europe

    The cyclotron is the centerpiece of the Penn Medicine | Virtua Health facility, which will provide a leading-edge form of cancer treatment starting in late 2022.

    FULL STORY AT Penn Medicine News

  • Diabetes medications linked to glaucoma prevention

    A popular class of diabetes medications called GLP-1R agonists may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the Perelman School of Medicine. 

    FULL STORY AT Penn Medicine News